| Primary |
| Hypertension |
54.1% |
| Essential Hypertension |
4.3% |
| Type 2 Diabetes Mellitus |
3.9% |
| Atrial Fibrillation |
3.6% |
| Renal Transplant |
3.6% |
| Hypercholesterolaemia |
3.3% |
| Acute Myeloid Leukaemia |
2.6% |
| Gastrointestinal Disorder |
2.6% |
| Bronchitis |
2.3% |
| Dyslipidaemia |
2.3% |
| Diabetes Mellitus |
2.0% |
| Neck Pain |
2.0% |
| Pain |
2.0% |
| Prophylaxis |
2.0% |
| Congestive Cardiomyopathy |
1.6% |
| Depression |
1.6% |
| Ill-defined Disorder |
1.6% |
| Myocardial Infarction |
1.6% |
| Urinary Tract Infection |
1.6% |
| Anaemia |
1.3% |
|
| Malaise |
12.2% |
| Orthostatic Hypotension |
11.2% |
| Renal Failure |
8.2% |
| Renal Failure Acute |
8.2% |
| Toxic Skin Eruption |
8.2% |
| Aplastic Anaemia |
6.1% |
| Thrombocytopenia |
6.1% |
| Pruritus |
5.1% |
| Vertigo |
5.1% |
| Extrapyramidal Disorder |
3.1% |
| Hyponatraemia |
3.1% |
| International Normalised Ratio Increased |
3.1% |
| Oedema Peripheral |
3.1% |
| Pulmonary Fibrosis |
3.1% |
| Rhabdomyolysis |
3.1% |
| Wrist Fracture |
3.1% |
| Cytolytic Hepatitis |
2.0% |
| Electrocardiogram T Wave Inversion |
2.0% |
| Eosinophilia |
2.0% |
| Femur Fracture |
2.0% |
|
| Secondary |
| Hypertension |
25.6% |
| Drug Use For Unknown Indication |
23.2% |
| Product Used For Unknown Indication |
19.0% |
| Type 2 Diabetes Mellitus |
3.2% |
| Prophylaxis Against Transplant Rejection |
2.8% |
| Atrial Fibrillation |
2.5% |
| Hypercholesterolaemia |
2.3% |
| Renal Transplant |
2.3% |
| Hiv Infection |
2.2% |
| Dyslipidaemia |
1.8% |
| Bronchitis |
1.7% |
| Epilepsy |
1.7% |
| Hypertensive Heart Disease |
1.7% |
| Ill-defined Disorder |
1.7% |
| Neck Pain |
1.7% |
| Congestive Cardiomyopathy |
1.5% |
| Diabetes Mellitus |
1.5% |
| Prophylaxis |
1.3% |
| Angina Pectoris |
1.2% |
| Schizophrenia |
1.2% |
|
| Orthostatic Hypotension |
10.5% |
| Renal Failure |
9.8% |
| Renal Failure Acute |
9.8% |
| Toxic Skin Eruption |
5.9% |
| Lung Disorder |
5.2% |
| Pruritus |
5.2% |
| Pyrexia |
5.2% |
| Rhabdomyolysis |
5.2% |
| Toxic Epidermal Necrolysis |
4.6% |
| Tubulointerstitial Nephritis |
4.6% |
| Vomiting |
4.6% |
| Renal Impairment |
3.9% |
| Hepatitis Cholestatic |
3.3% |
| Hyponatraemia |
3.3% |
| Malaise |
3.3% |
| Memory Impairment |
3.3% |
| Posterior Reversible Encephalopathy Syndrome |
3.3% |
| Tendon Rupture |
3.3% |
| Thrombocytopenia |
3.3% |
| Fall |
2.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
33.2% |
| Hypertension |
18.1% |
| Product Used For Unknown Indication |
17.9% |
| Prophylaxis |
3.3% |
| Diabetes Mellitus |
2.7% |
| Type 2 Diabetes Mellitus |
2.5% |
| Atrial Fibrillation |
2.4% |
| Pain |
2.2% |
| Hiv Infection |
2.2% |
| Renal Transplant |
2.0% |
| Depression |
1.9% |
| Thrombosis Prophylaxis |
1.7% |
| Hypercholesterolaemia |
1.5% |
| Prophylaxis Against Transplant Rejection |
1.5% |
| Rheumatoid Arthritis |
1.3% |
| Anxiety |
1.3% |
| Osteoporosis |
1.1% |
| Hepatitis C |
1.1% |
| Colorectal Cancer Metastatic |
1.1% |
| Ill-defined Disorder |
1.0% |
|
| Renal Failure Acute |
14.3% |
| Thrombocytopenia |
10.8% |
| Vomiting |
10.8% |
| Renal Failure |
6.9% |
| Pyrexia |
5.9% |
| Toxic Skin Eruption |
5.1% |
| Weight Decreased |
4.7% |
| Malaise |
4.1% |
| Syncope |
4.1% |
| Hyponatraemia |
3.7% |
| Rhabdomyolysis |
3.7% |
| International Normalised Ratio Increased |
3.3% |
| Neutropenia |
3.3% |
| Myocardial Infarction |
2.9% |
| Pulmonary Embolism |
2.9% |
| Tremor |
2.9% |
| Weight Increased |
2.9% |
| Pancreatitis Acute |
2.7% |
| Subdural Haematoma |
2.7% |
| Tachycardia |
2.7% |
|
| Interacting |
| Product Used For Unknown Indication |
33.3% |
| Drug Use For Unknown Indication |
24.2% |
| Hypercholesterolaemia |
12.1% |
| Hypertension |
12.1% |
| Ischaemic Cardiomyopathy |
12.1% |
| Myocardial Ischaemia |
6.1% |
|
| Orthostatic Hypotension |
40.0% |
| Hepatotoxicity |
30.0% |
| Muscle Disorder |
10.0% |
| Pain In Extremity |
10.0% |
| Psoriasis |
10.0% |
|
